(1 - 6 von 6
)
BioLineRx Announces In-licensing of Liver Fibrosis Project Under...
pipelinereview.com
BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Contact: Gaby Rohe Contact:Principal Investigator: Rifaat Safadi, Dr.
Vacunación COVID-19 en pacientes con enfermedad hepáticaasscat-hepatitis.org › eventos › webinar-easl-vacunacio...
asscat-hepatitis.org
Mar 9, · Verena Keitel, Hospital Universitario de Düsseldorf, Alemania Rifaat Safadi, Hadassah Medical Centers of the Hebrew, Universidad de ...
Chemomab Announces Late-Breaking Presentation of CM-101 First...
www.prnewswire.com
· Presented by: Rifaat Safadi, Head of Liver unit, Hadassah medical center, Israel. In the Liver Meeting Digital Experience™ Chemomab ...
Story | Liver Disease Is Linked to Weaker Response to COVID-19 Vaccine
www.hadassah.org
· Rifaat Safadi, director of the Liver Unit at Hadassah Hospital Ein Kerem, has found that his patients who received liver transplants and those ...
New Data From Hadassah Medical Center Lab Show Can-Fite’s Namodenoson...
apnews.com
· Rifaat Safadi's lab demonstrate that Namodenoson induces weight loss in experimental models and normalizes glucose levels. Dr. Safadi is Head of ...
sortiert nach Relevanz / Datum